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Results: Basal blood pressure, heart rate, basal forearm blood flow, NTG% and body 
weight were similar between groups. FMD was greater in group A (72.9±7.6%) than in 
groups B (43.7+/-5.1%, p<0.05) or C (53.4+/-7.1%, p<0.05). No significant difference of 
FMD was observed between groups B (43.7±5.1%) and C (53.4±7.1%, p=NS). Ejection 
fraction was greater in group A (51±3.1%) than in groups B (26.0±0.93%, p<0.001) and 
C (24.1±1.0%, p<0.001), but no difference was observed in ejection fraction between 
groups B and C (p=NS). 
Conclusions: There is no significant difference in endothelial function between patients 
with ischemic and dilated cardiomyopathy. These findings indicate that undedying ath- 
erosclerosis plays a minor role in endothelial dysfunction in patients with heart failure. 
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Background: tt is well established that patients with diabetes mellitus (DM) are at 
increased risk for cardiovascular disease (CVD). There is also increasing interest in the 
role of hyperhomocysteinemia s potential determinant of CVD. The impact of hyperho- 
mooystainemia in this high-risk population remains however to be clarified. The purpose 
of this study is to assess prospectively the relationship between elevated plasma 
homocystaine (tHcy) levels (>13 I~mol/mL) and risk of CVD (stroke, myocardial infarction 
and CVD death) in DM patients. 
Methods: This is a sub analysis from the Veterans Affair High-Density Lipoprotain Cho- 
lesterol Intervention Trial (VA-HIT), performed on 834 men with documented CVD and 
recruited from 20 VA medical centers throughout the United States. Baseline blood sam- 
ples were examined for plasma tHcy in 358 patients who presented with a new CVD 
event over the 5.1 -year follow-up and 476 age-matched controls. 
Results: The mean age of study participants was 66 year old, and the prevalence of dia- 
betes was 23%. Mean plasma tHcy levels were 10.9 Ilmol/L in the non-DM group and 
10.4 ;~mol/L in the DM group. For DM patients with elevated plasma tHcy levels, the 5.1- 
year cumulative risk of a new CVD event was 64%, whereas it was 50 % in DM patients 
with normal tHcy levels, 44% in non-DM patients with high plasma tHey, and 38% in non- 
DM patients with normal plasma tHcy levels (reference group) (p=0.O04). Adjusted Haz- 
ard Ratios (for age, hypertension, hyperinsutinemia, lipide, folata, vitamin B6 and creati- 
nine) for a new CVD event were 1.78 (p=0,01) in the DM group with high tHcy levels, 
1.29 (p=0.08) in DM patients with normal plasma tHcy and 1.06 (p=0.69) in non-DM 
patients with elevated plasma tHcy, compared to the reference group. 
Conclusion: These results demonstrate an important adverse role of elevated plasma 
tHcy on the risk of a new event in DM patients with known CVD. Hyperhomocysteinemia, 
like hypertension and dyslipidemia, should probably be screened in this high-risk popula- 
tion of patients since treatment might improve their cardiovascular outcomes. 
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Background: Increased oxidative stress has been implicated as a potential mechanism 
for abnormal endothelial vasomotor function. Vitamin C is the main water soluble anfioxi- 
dant in human plasma and L-arginine is the substrate for nitric oxide synthesis. We 
assessed the effects of vitamin C on the vasomotor esponses of L-arginine administra- 
tion in epicardial coronary arteries, 
Methods: In 5 patients (3 males, 2 females; mean aged 59±9 years) with coronary artery 
disease (CAD) and stable angina we infused normal saline (NS) and 150 pmol/min L- 
arginine intracoronary before and after intravenous infusion of vitamin C 25 mg/min for 
15 minutes. The diameter of proximal and distal coronary artery segments was mea- 
sured by quantitative angiegraphy at baseline and after infusion of normal saline, L-argi- 
nine, vitamin C and vitamin C with L-arginine. 
Results: The infusion of L-arginine did not affect the systolic blood pressure 
(mean±SEM) (136±9 vs 133¢8 mmHg, p=NS), or heart rate (65±3.4 vs 69±2.7 beats/ 
min, p=NS). L-arginine administration was associated with dilation of coronary segments 
(from 2.29±0.2 mm to 2.44±0.22 mm (8.0±1,9%, p=0.001 vs normal saline). With the co* 
infusion of vitamin C and L-arginine, coronary segments dilated to 2.54±0.21 mm 
(13.4±2%, p<0.01 vs normal saline, p<O.01 vs L-arginine). 
Conclusions: Our results show augmentation of the L-arginine dependent distal coronary 
segment vasodilation by the antioxidant vitamin C in patients with atherosclerosis. The 
beneficial effects of vitamin C on the L-arginine nitric oxide pathway in patients with ath- 
erosclerosis represents a potential therapeutic target in the treatment of coronary artery 
disease. 
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Background: inflammatory state is associated with the activation of the inducible nitric 
oxide synthase (iNOS). Massive synthesis of nitric oxide (NO) that ensues leads to sys- 
temic changes in vascular reactivity and may cause mesenteric ischemic events. Our 
objectives were to develop a model for the study of mesenterio vascular reactivity in 
endotoxemia, in which iNOS is highly activated, and to evaluate a selective iNOS inhibi- 
tor, aminoguanidine (AMG) in restoring vascular reactivity. Methods: Vascular reactivity 
studies were performed on isolated intestines from Sprague-Dawtey rats. The isolated 
intestines were perfusad with Krabs-Ringer solution (37°C; 95% 02; 5% CO2) at physio- 
logical pressure (80 cm H20). Flow variations were recorded for vascular reactivity study. 
Studies were conducted in control rats (n=9), endotoxemic rats (LPS 20 mg/kg; n=6) and 
endotoxemic rats pretreated with AMG 200 mg/kg (AMG + LPS, n=6). Endotoxemia was 
obtained by intrapedtooeal injection of LPS 4 hours prior to surgery. Results: Evaluation 
of vascular contractility with phenylephrine 10-6 M showed significant impairment in the 
LPS group which was prevented by AMG pretreatment(-delta flow, control: 13.7±2.4 mL/ 
rain; LPS: 6.3±2.0 mL/min; AMG+LPS: 11.0¢2.4 mlJmin, p<0.0f). Stimulation of iNOS 
activity by administration of L-Arginine 10-4 M, showed significant vasodilation in the LPS 
group which was highly inhibited by AMG(delta flow, control: 0.4±1.7 mlJmin; LPS: 
4.0±0.7 mL/min; AMG+LPS: 1.1± 2.4 mL/min, p<0.05). Endothelial relaxation with acetyl- 
choline 10-6 M was blunted in the LPS group and restored by AMG (delta flow, control: 
8.6±3.0 mlJmin; LPS: -0.7±0.8 mL/min; AMG+LPS: 6.4±1.5 mL/min, p<O.01).lmmuno- 
histochemistry studies confirmed the presence of iNOS in both the LPS group and 
AMG+LPS group. Conclusion: Aminoguanidine restores vascular contractility and endot- 
helial synthesis of NO in endotoxemia nd may contribute to vascular and intestinal 
integrity in processes associated with iNOS activation. 
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BACKGROUND. Alcohol intake is considered to have ambiguous effect on the cardio- 
vascular risk, especially compared to other well-established risk factors. The aim of this 
study is to investigate the association between alcohol consumption and other clinical 
and biochemical parameters in cardiovascular disease free men and women. 
METHODS. The ATTICA study is a prospective population -based cohort designed to 
enroll 3073 men and women from the greater area of Athens. A random algorithm was 
developed and stratified, by sex- age; sampling was performed, dudng 2001. In this work 
we analyzed data from 520 men (18-86 years old) and 580 women (18-80 years old). 
Using multiple regression analysis we investigated the association between arterial dias- 
tolic blood pressure (DBP), fibrinogen, glucose concentration, total cholesterol levels, 
HDL, apo A1, apo B, Lp(a), uric acid, triglycerides and alcohol consumption. 
RESULTS. A J-shape association was found between alcohol intake (none, 1-2, 3-4, 5+ 
wine glasses/day) and tibrinogen levels (307±50 vs. 287±48 vs. 300±49 vs. 330±52 mgr/ 
dl, P=0.047), as well as DBP (76±9 vs. 74±8 vs. 82±10 vs. 84±11 mm Hg, P=O.006), glu- 
cose levels (92±20 vs. 88±26 vs. 100±30 vs. 110±31 mgr/dl P=0.015), HDL (50±16 vs. 
53±17 vs. 47±11 vs. 45±10 mgr/dl, P=0.041, apoA1 (162±35 vs. 168±28 vs. 155±25 vs. 
145±25mgr/dl, P=0.037), apoB (112±23 vs. 106±18 vs, 114±17 vs. 125±19 mgr/dl, 
P=0.04), uric acid (4.26±0.75 vs. 4.09±0.53 vs. 4.76±1.01 vs. 5±1.2 mgr/dl, P=0.009). 
Also positive associations were found between atcohol intake and total cholesterol levels 
(206±29 vs. 212±28 vs. 222±30 vs. 235±31mgr/di, P=0.024), Lp(a) (17±5 vs. 19±6 vs. 
20±8 vs. 23±7mgr/dl P=0.035) and triglycerides (115¢39 vs. 116±38 vs. 164±40 vs. 
179±41mgr/dl, P=0.008). The previous associations were confirmed from multivadata 
analysis after taking into account age, sex, smoking habits, lipidemic medication, dietary 
patterns and physical activity levels. 
CONCLUSIONS. The controversial association between alcohol intake and cardiovascu- 
lar disease can be partially explained through the J-shape relation between several bio- 
chemical parameters related to atherosclerosis and the amount of alcohol consumption. 
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Wei-Chuan Teal, Yi-Heng Li, Chih-Chan Lin, Ting-Hsing ChaD, Jyh-Hong Chen, National 
Cheng Kung University Hospital, Tainan, Taiwan,ROC. 
Background: Impairment of flow-mediated vasodilatation (FMD) was noted following a 
high-tat meal. TO investigate whether oxidative stress is increased after a high-fat meal, 
we measured serum glutathione peroxidase (GP), an antioxidative enzyme, and urine 
excretion of 8-epi-prostaglandin F2c((8-PGF2*x), a free radical-catalyzed product from 
oxidative modification of arachidonic acid in this study. 
Methods: Sixteen healthy men (mean age 30 + 5, range 21-39 years) without major risk 
factors were included in this study. High-resolution ultrasound was used to assess the 
FMD of brachial artery. Blood and urine samples were collected before, 2 hours after, 4 
hours after, and 6 hours after a standard high-fat meal (3766 J, 900 Kcal, 50 g fat, 14 g 
saturated fat, 225 mg cholesterol). Serum GP and urine 8-PGF2c( were measured by 
using validated enzyme immunoassay. Excretion of 8-PGF2c( was determined from urine 
8-PGF2c( divided by urine creatinine. 
Results: Serum triglyceride increased significantly from 138 _+ 79 mg/dl before meal to 
